132 related articles for article (PubMed ID: 18583950)
1. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study.
Obołończyk Ł; Siekierska-Hellmann M; Wiśniewski P; Lewczuk A; Berendt-Obołończyk M; Lakomy A; Michalska Z; Radowska D; Moszkowska G; Bianek-Bodzak A; Sworczak K
Postepy Hig Med Dosw (Online); 2017 Sep; 71(0):842-849. PubMed ID: 29039351
[TBL] [Abstract][Full Text] [Related]
3. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
[TBL] [Abstract][Full Text] [Related]
4. Interferon-induced thyroiditis during treatment of chronic hepatitis C.
Kozielewicz D; Halota W
Endokrynol Pol; 2012; 63(1):66-70. PubMed ID: 22378101
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin--a review.
Andrade LJ; Atta AM; D'Almeida Junior A; Paraná R
Braz J Infect Dis; 2008 Apr; 12(2):144-8. PubMed ID: 18641852
[TBL] [Abstract][Full Text] [Related]
7. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
Gill G; Bajwa H; Strouhal P; Buch HN
J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
[TBL] [Abstract][Full Text] [Related]
8. Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin.
Paraná R; Cruz M; Santos-Jesus R; Ferreira K; Codes L; Cruz T
Braz J Infect Dis; 2000 Dec; 4(6):284-90. PubMed ID: 11136525
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha induced transient thyroid dysfunction in hepatitis C.
Fernández-Díez S; Rodríguez-Agulló JL; Cascudo Rielo MJ; Navarro Angulo N; Díaz-Rubio M
Rev Esp Enferm Dig; 2002 Mar; 94(3):159-63. PubMed ID: 12185880
[TBL] [Abstract][Full Text] [Related]
10. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
[TBL] [Abstract][Full Text] [Related]
11. Thyroid dysfunction during interferon alpha therapy for chronic hepatitis C.
Shen L; Bui C; Mansberg R; Nguyen D; Alam-Fotias S
Clin Nucl Med; 2005 Aug; 30(8):546-7. PubMed ID: 16024950
[TBL] [Abstract][Full Text] [Related]
12. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
[TBL] [Abstract][Full Text] [Related]
13. Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C.
Sachithanandan S; Clarke G; Crowe J; Fielding JF
J Interferon Cytokine Res; 1997 Jul; 17(7):409-11. PubMed ID: 9243373
[TBL] [Abstract][Full Text] [Related]
14. [Thyrotoxicosis induced by interferonotherapy of chronic hepatitis C in a woman with Hashimoto's thyroiditis].
Kozielewicz D; Junik R; Halota W
Pol Merkur Lekarski; 2014 Aug; 37(218):108-10. PubMed ID: 25252446
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations.
Ward DL; Bing-You RG
Endocr Pract; 2001; 7(1):52-8. PubMed ID: 11250770
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha and autoimmune thyroid disease.
Prummel MF; Laurberg P
Thyroid; 2003 Jun; 13(6):547-51. PubMed ID: 12930598
[TBL] [Abstract][Full Text] [Related]
17. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification.
Mandac JC; Chaudhry S; Sherman KE; Tomer Y
Hepatology; 2006 Apr; 43(4):661-72. PubMed ID: 16557537
[TBL] [Abstract][Full Text] [Related]
18. Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.
Mammen JS; Ghazarian SR; Rosen A; Ladenson PW
Thyroid; 2013 Sep; 23(9):1151-8. PubMed ID: 23517287
[TBL] [Abstract][Full Text] [Related]
19. Cases of interferon-alpha and interferon-beta-induced thyroiditis.
Nonchev BI
Folia Med (Plovdiv); 2010; 52(3):5-12. PubMed ID: 21053668
[TBL] [Abstract][Full Text] [Related]
20. Side effects of alpha interferon in chronic hepatitis C.
Dusheiko G
Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
